# Efficacy of Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients

> **NCT07030855** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Semmelweis University** · enrollment: 56 (estimated)

## Conditions studied

- Acute Bronchitis

## Interventions

- **COMBINATION_PRODUCT:** Elixirium thymi compositum (FoNo VIII.)
- **COMBINATION_PRODUCT:** Elixirium thymi compositum (FoNo VIII.) placebo

## Key facts

- **NCT ID:** NCT07030855
- **Lead sponsor:** Semmelweis University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-07
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07030855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07030855, "Efficacy of Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07030855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*